Affimed N.V. (AFMD) has received notice from Nasdaq that its common shares will be delisted from the exchange. Trading of AFMD shares will be suspended on May 20, 2025, following the company’s insolvency filing in the Mannheim court, Germany, on May 13, 2025.
The delisting decision is based on three key factors: public interest concerns following the insolvency filing, concerns about existing shareholders’ residual equity interest, and doubts about the company’s ability to maintain Nasdaq listing requirements. Affimed does not plan to appeal this determination.
Affimed N.V. (AFMD) ha ricevuto comunicazione da Nasdaq riguardo alla rimozione delle sue…
